Chevy Chase, MD, United States of America

Triantafylios Chavakis


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Triantafylios Chavakis

Introduction

Triantafylios Chavakis is a notable inventor based in Chevy Chase, MD. He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis. His work focuses on the inhibition of angiogenesis, which is crucial for various medical applications.

Latest Patents

Chavakis holds a patent titled "Inhibition of angiogenesis by neutrophil alpha-defensins." This invention relates to the inhibition of angiogenesis through the action of neutrophil alpha-defensins. The patent outlines methods that involve inhibiting endothelial cell adhesion to the extracellular matrix, promoting endothelial cell apoptosis, and reducing endothelial cell angiogenesis mediated by alpha-defensins.

Career Highlights

Chavakis is affiliated with the University of Pennsylvania, where he continues to advance his research. His work has implications for treating various diseases where angiogenesis plays a critical role, such as cancer and inflammatory conditions.

Collaborations

Some of his notable coworkers include Douglas B. Cines and Khalil Bdeir, who have collaborated with him on various research projects.

Conclusion

Triantafylios Chavakis is a prominent figure in the field of biomedical innovation, with a focus on angiogenesis and its inhibition. His contributions are paving the way for new therapeutic strategies in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…